Keydar I - Search Results

1

The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients.

Yaal-Hahoshen N, Shina S, Leider-Trejo L, Barnea I, Shabtai EL, Azenshtein E, Greenberg I, Keydar I, Ben-Baruch A. Yaal-Hahoshen N, et al. Among authors: keydar i. Clin Cancer Res. 2006 Aug 1;12(15):4474-80. doi: 10.1158/1078-0432.CCR-06-0074. Clin Cancer Res. 2006. PMID: 16899591 Review.

2

Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.

Soria G, Yaal-Hahoshen N, Azenshtein E, Shina S, Leider-Trejo L, Ryvo L, Cohen-Hillel E, Shtabsky A, Ehrlich M, Meshel T, Keydar I, Ben-Baruch A. Soria G, et al. Among authors: keydar i. Cytokine. 2008 Oct;44(1):191-200. doi: 10.1016/j.cyto.2008.08.002. Epub 2008 Sep 13. Cytokine. 2008. PMID: 18790652

3

The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity.

Azenshtein E, Luboshits G, Shina S, Neumark E, Shahbazian D, Weil M, Wigler N, Keydar I, Ben-Baruch A. Azenshtein E, et al. Among authors: keydar i. Cancer Res. 2002 Feb 15;62(4):1093-102. Cancer Res. 2002. PMID: 11861388

4

Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease.

Wigler N, Shina S, Kaplan O, Luboshits G, Chaitchik S, Keydar I, Ben-Baruch A. Wigler N, et al. Among authors: keydar i. Isr Med Assoc J. 2002 Nov;4(11 Suppl):940-3. Isr Med Assoc J. 2002. PMID: 12455185

5

The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors.

Azenshtein E, Meshel T, Shina S, Barak N, Keydar I, Ben-Baruch A. Azenshtein E, et al. Among authors: keydar i. Cancer Lett. 2005 Jan 10;217(1):73-86. doi: 10.1016/j.canlet.2004.05.024. Cancer Lett. 2005. PMID: 15596298

6

Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma.

Luboshits G, Shina S, Kaplan O, Engelberg S, Nass D, Lifshitz-Mercer B, Chaitchik S, Keydar I, Ben-Baruch A. Luboshits G, et al. Among authors: keydar i. Cancer Res. 1999 Sep 15;59(18):4681-7. Cancer Res. 1999. PMID: 10493525

7

MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.

Zaretsky JZ, Barnea I, Aylon Y, Gorivodsky M, Wreschner DH, Keydar I. Zaretsky JZ, et al. Among authors: keydar i. Mol Cancer. 2006 Nov 5;5:57. doi: 10.1186/1476-4598-5-57. Mol Cancer. 2006. PMID: 17083744 Free PMC article.

8

Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker.

Golan M, Hizi A, Resau JH, Yaal-Hahoshen N, Reichman H, Keydar I, Tsarfaty I. Golan M, et al. Among authors: keydar i. Neoplasia. 2008 Jun;10(6):521-33. doi: 10.1593/neo.07986. Neoplasia. 2008. PMID: 18516289 Free PMC article.

9

Antibody internalization studied using a novel IgG binding toxin fusion.

Mazor Y, Barnea I, Keydar I, Benhar I. Mazor Y, et al. Among authors: keydar i. J Immunol Methods. 2007 Apr 10;321(1-2):41-59. doi: 10.1016/j.jim.2007.01.008. Epub 2007 Feb 6. J Immunol Methods. 2007. PMID: 17336321

10

Prognostic factors in breast cancer--a pathological and immunological study of patients with stage 1 breast cancer.

Chaitchik S, Kabakow B, De Chabon A, Jonson JJ, Bar-Eyal A, Selzer G, Feuer EJ, Keydar I, Hizi A. Chaitchik S, et al. Among authors: keydar i. Eur J Surg Oncol. 1987 Dec;13(6):499-504. Eur J Surg Oncol. 1987. PMID: 2826257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters